Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Starpharma logo — Starpharma is a global biopharmaceutical company and a world...

Starpharma

Starpharma is a global biopharmaceutical company and a world leader in the development of dendrimers.

Founded 1996 Australia Australia 84 employees Total: $45.10M Biotechnology, Manufacturing +1

General Information

Company Name Starpharma
Founded Year 1996
Location Australia Australia
Employees 84
Industries Biotechnology, Manufacturing, Pharmaceutical
Business Model B2B, Platform, B2B2C
Revenue Model Licensing, Product Sales, Project Based
Social

BounceWatch is an independent company data service, not affiliated with Starpharma. To contact Starpharma, visit starpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Starpharma compare?

A PDF of Starpharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Starpharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Starpharma

Starpharma, founded in 1996, is an Australian-based, global biopharmaceutical company recognized as a leader in the development of dendrimers—proprietary polymers pivotal in drug formulation. Their innovative focus is on advancing pharmaceutical and medical products targeting key areas, including respiratory viruses, DEP® drug delivery, and VivaGel®.

Positioned within the Biotechnology, Manufacturing, and Pharmaceutical industries, Starpharma boasts a significant track record, underscored by a pivotal $45.00M investment in private placement received on 01 September 2020. This financial backing highlights investor confidence in their cutting-edge technology and growth potential.

As a constantly evolving entity within the global bio-pharmaceutical landscape, Starpharma presents a robust proposition for potential investors seeking investment opportunities in pioneering biotech innovations.

Business keywords: biopharmaceutical, dendrimers, drug development, DEP® drug delivery, VivaGel®, synthetic polymers, respiratory viruses, life sciences, medical applications, agrochemicals, nanotechnology, pharmaceutical partnerships, nanoscale polymer, polymeric drug delivery

Services & Products

Dendrimer Technology Development
Drug Delivery Solutions
Research and Publication
Partnership Opportunities

Target Customers

Investors Pharmaceutical Companies Healthcare Industry Research Institutions

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Private Placement VC $45.00M -
01 Sep 2020
Grant $50.00K 1
Innovation Connections
01 Oct 2017
Grant $50.00K 1
Innovation Connections
01 Feb 2016
IPO Undisclosed -
01 Jan 2005
Spinout Undisclosed 1
CSIRO
01 Mar 1996

Starpharma Alternatives & Competitors

View All Alternatives
Starpharma vs
Apidel
Apidel

Revolutionizing Therapeutics through Cutting-Edge Drug Delivery Solutions

Series C
Biotechnology, Pharmaceutical
Starpharma vs
Cristal Therapeutics
Cristal Therapeutics The Netherlands

CliCr as next generation metal-free click chemistry for faster, cheaper and better bioconjugate prod...

Grant
4 employees
Biotechnology, Health and Wellness
Starpharma vs
SolAeroMed Inc.
SolAeroMed Inc.

Visit the post for more.

Seed
3 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Starpharma

Starpharma is a global biopharmaceutical company and a world leader in the development of dendrimers.
Starpharma was founded in 1996.
Starpharma is headquartered in Australia.
Starpharma operates in Biotechnology, Manufacturing and Pharmaceutical. Its work centres on biopharmaceutical, dendrimers, drug development and DEP® drug delivery. Its customers include Investors, Pharmaceutical Companies and Healthcare Industry.
Starpharma has a B2B, Platform and B2B2C business model. Its revenue comes from Licensing, Product Sales and Project Based.
Starpharma has approximately 84 employees.
Starpharma has completed 5 funding rounds, raising a total of $45.10M.
Starpharma offers: Dendrimer Technology Development, Drug Delivery Solutions, Research and Publication, Partnership Opportunities.
Top alternatives and competitors to Starpharma include Apidel, Cristal Therapeutics, SolAeroMed Inc., Biohaven, Pulmobiotics SL. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Starpharma and Apidel are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Starpharma, https://bouncewatch.com/company/starpharma, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes